Linked Life Data

7519170

Source:http://linkedlifedata.com/resource/pubmed/id/7519170

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7519170rdf:typepubmed:Citationlld:pubmed
pubmed-article:7519170lifeskim:mentionsumls-concept:C0025919lld:lifeskim
pubmed-article:7519170lifeskim:mentionsumls-concept:C0026845lld:lifeskim
pubmed-article:7519170lifeskim:mentionsumls-concept:C0034792lld:lifeskim
pubmed-article:7519170lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:7519170lifeskim:mentionsumls-concept:C0017963lld:lifeskim
pubmed-article:7519170lifeskim:mentionsumls-concept:C0443146lld:lifeskim
pubmed-article:7519170lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:7519170lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:7519170lifeskim:mentionsumls-concept:C1709915lld:lifeskim
pubmed-article:7519170lifeskim:mentionsumls-concept:C0205431lld:lifeskim
pubmed-article:7519170lifeskim:mentionsumls-concept:C1321758lld:lifeskim
pubmed-article:7519170pubmed:issue1lld:pubmed
pubmed-article:7519170pubmed:dateCreated1994-8-31lld:pubmed
pubmed-article:7519170pubmed:abstractTextBALB/c mice develop myasthenic symptoms after immunization with rodent acetylcholine receptor (AChR). After immunization with Torpedo AChR (TAChR), their CD4+ cells become strongly sensitized against a conserved region of the TAChR alpha subunit sequence (residues alpha 304-322), and cross-react vigorously with the homologous sequences of mouse and human AChR, which are almost identical. Therefore AChR-specific potentially autoreactive CD4+ cells exist in this strain. We immunized BALB/c mice with the synthetic TAChR sequence alpha 304-322. The CD4+ cells thus sensitized responded to TAChR, indicating that they recognize an epitope(s) produced upon TAChR processing. They recognized peptide alpha 304-322 in association with the I-Ad molecule. Anti-alpha 304-322 CD4+ cells cross-reacted well with the corresponding murine and human synthetic sequences. To identify residues involved in formation of an autoimmune epitope(s), CD4+ cells from mice immunized with peptide alpha 304-322 were challenged in vitro with single residue glycine-substituted analogues of this sequence. Substitution of residue W311, and of any residue within the sequence alpha 313-319 (RKVFIDT), consistently and, in some cases, strongly affected the CD4+ cells response. Substitution of residues in the region alpha 311-319 had variable effects in different experiments, and in general affected moderately the CD4+ response. These results suggest that anti-alpha 304-322 CD4+ cells comprise several clones, recognizing overlapping epitopes which share residues alpha 311-319. The importance of the sequence region alpha 311-319 for formation of CD4+ cell epitope(s) was verified by testing CD4+ cells sensitized to T alpha 304-322 with analogues of this sequence, carrying non-conservative substitutions at positions Q310, K314 and D318. Substitution of Q310 had minimal or no effects, while those of K314 or D318 strongly affected the CD4+ cell response.lld:pubmed
pubmed-article:7519170pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:languageenglld:pubmed
pubmed-article:7519170pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:citationSubsetIMlld:pubmed
pubmed-article:7519170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519170pubmed:statusMEDLINElld:pubmed
pubmed-article:7519170pubmed:monthMaylld:pubmed
pubmed-article:7519170pubmed:issn0019-2805lld:pubmed
pubmed-article:7519170pubmed:authorpubmed-author:Conti-Troncon...lld:pubmed
pubmed-article:7519170pubmed:authorpubmed-author:BelloneMMlld:pubmed
pubmed-article:7519170pubmed:authorpubmed-author:OstlieNNlld:pubmed
pubmed-article:7519170pubmed:authorpubmed-author:KarachunskiP...lld:pubmed
pubmed-article:7519170pubmed:issnTypePrintlld:pubmed
pubmed-article:7519170pubmed:volume82lld:pubmed
pubmed-article:7519170pubmed:ownerNLMlld:pubmed
pubmed-article:7519170pubmed:authorsCompleteYlld:pubmed
pubmed-article:7519170pubmed:pagination22-7lld:pubmed
pubmed-article:7519170pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:meshHeadingpubmed-meshheading:7519170-...lld:pubmed
pubmed-article:7519170pubmed:year1994lld:pubmed
pubmed-article:7519170pubmed:articleTitleResidues within the alpha subunit sequence 304-322 of muscle acetylcholine receptor forming autoimmune CD4+ epitopes in BALB/c mice.lld:pubmed
pubmed-article:7519170pubmed:affiliationDepartment of Biochemistry, College of Biological Sciences, University of Minnesota, Minneapolis, St. Paul 55108.lld:pubmed
pubmed-article:7519170pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7519170pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7519170pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed